Allstate (NYSE:ALL) Price Target Increased to $215.00 by Analysts at Morgan Stanley

Allstate (NYSE:ALL - Free Report) had its target price upped by Morgan Stanley from $202.00 to $215.00 in a research note released on Monday morning, Benzinga reports. Morgan Stanley currently has an overweight rating on the insurance provider's stock.

A number of other research firms have also recently commented on ALL. Keefe, Bruyette & Woods boosted their price target on shares of Allstate from $199.00 to $208.00 and gave the stock an "outperform" rating in a research note on Monday, August 12th. StockNews.com cut shares of Allstate from a "strong-buy" rating to a "buy" rating in a report on Wednesday, August 21st. JPMorgan Chase & Co. upped their price target on shares of Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. Wells Fargo & Company reduced their target price on Allstate from $177.00 to $175.00 and set an "equal weight" rating for the company in a report on Friday, August 16th. Finally, TD Cowen raised their target price on shares of Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a report on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Allstate presently has a consensus rating of "Moderate Buy" and a consensus target price of $206.44.

Allstate Trading Down 1.4 %

NYSE ALL traded down $2.73 during mid-day trading on Monday, reaching $192.64. 1,163,079 shares of the stock were exchanged, compared to its average volume of 1,546,520. Allstate has a one year low of $121.70 and a one year high of $198.79. The stock has a 50 day simple moving average of $187.08 and a 200-day simple moving average of $173.96. The stock has a market cap of $50.84 billion, a P/E ratio of 42.53, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion during the quarter, compared to analysts' expectations of $14.04 billion. During the same period last year, the company posted ($4.42) earnings per share. The business's quarterly revenue was up 12.4% on a year-over-year basis. On average, analysts anticipate that Allstate will post 15.19 EPS for the current year.

Insider Transactions at Allstate

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the business's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider John E. Dugenske sold 36,367 shares of the business's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company's stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Foundations Investment Advisors LLC lifted its stake in shares of Allstate by 461.9% during the 3rd quarter. Foundations Investment Advisors LLC now owns 38,658 shares of the insurance provider's stock worth $7,331,000 after purchasing an additional 31,778 shares during the last quarter. Horst & Graben Wealth Management LLC acquired a new position in Allstate during the 3rd quarter valued at approximately $204,000. Northwest Investment Counselors LLC acquired a new stake in shares of Allstate during the third quarter worth $28,000. Livelsberger Financial Advisory acquired a new stake in shares of Allstate during the third quarter worth $136,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock valued at $569,114,000 after buying an additional 472,040 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.